(Q59632262)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21308494%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

title

TLR, NLR Agonists, and Other Immune Modulators as Infectious Disease Vaccine Adjuvants (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21308494%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

0 references

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21308494%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

author name string

Sarah C Higgins

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21308494%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

publication date

1 January 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21308494%20AND%20SRC:MED&resulttype=core&format=json

Current infectious disease reports

22 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21308494%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21308494%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

page(s)

4-12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21308494%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21308494%20AND%20SRC:MED&resulttype=core&format=json

Clinical setbacks for toll-like receptor 9 agonists in cancer

22 January 2020

cites work

1 reference

12 December 2020

Adjuvant-enhanced antibody responses in the absence of toll-like receptor signaling

1 reference

12 December 2020

The path to a successful vaccine adjuvant--'the long and winding road'.

1 reference

12 December 2020

Attenuating regulatory T cell induction by TLR agonists through inhibition of p38 MAPK signaling in dendritic cells enhances their efficacy as vaccine adjuvants and cancer immunotherapeutics.

1 reference

12 December 2020

Interchangeability and tolerability of a virosomal and an aluminum-adsorbed hepatitis A vaccine

1 reference

12 December 2020

Innate immune recognition

1 reference

12 December 2020

A double-blind randomized placebo-controlled phase III study of a Pseudomonas aeruginosa flagella vaccine in cystic fibrosis patients

1 reference

12 December 2020

Toll-like receptors and innate immunity

1 reference

12 December 2020

Dendritic cells internalize vaccine adjuvant after intramuscular injection

1 reference

12 December 2020

Synthetic TLR agonists reveal functional differences between human TLR7 and TLR8.

1 reference

12 December 2020

A signaling polypeptide derived from an innate immune adaptor molecule can be harnessed as a new class of vaccine adjuvant

1 reference

12 December 2020

Characterization of cationic liposomes based on dimethyldioctadecylammonium and synthetic cord factor from M. tuberculosis (trehalose 6,6'-dibehenate)-a novel adjuvant inducing both strong CMI and antibody responses

1 reference

12 December 2020

Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8

1 reference

12 December 2020

Cytoplasmic flagellin activates caspase-1 and secretion of interleukin 1beta via Ipaf

1 reference

12 December 2020

MF59 emulsion is an effective delivery system for a synthetic TLR4 agonist (E6020).

1 reference

12 December 2020

Adjuvanticity of a synthetic cord factor analogue for subunit Mycobacterium tuberculosis vaccination requires FcRgamma-Syk-Card9-dependent innate immune activation

1 reference

12 December 2020

Toll-dependent selection of microbial antigens for presentation by dendritic cells

1 reference

12 December 2020

Analysis of adverse events of potential autoimmune aetiology in a large integrated safety database of AS04 adjuvanted vaccines

1 reference

12 December 2020

TLR-independent induction of dendritic cell maturation and adaptive immunity by negative-strand RNA viruses.

1 reference

12 December 2020

Signalling through C-type lectin receptors: shaping immune responses

1 reference

12 December 2020

Mucosal administration of flagellin induces innate immunity in the mouse lung

1 reference

12 December 2020

IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction

1 reference

12 December 2020

Molecular and cellular signatures of human vaccine adjuvants.

1 reference

12 December 2020

Cutting edge: inflammasome activation by alum and alum's adjuvant effect are mediated by NLRP3.

1 reference

12 December 2020

TLR4 mediates vaccine-induced protective cellular immunity to Bordetella pertussis: role of IL-17-producing T cells.

1 reference

12 December 2020

Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization

1 reference

12 December 2020

Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway

1 reference

12 December 2020

In vivo activity of released cell wall lipids of Mycobacterium bovis bacillus Calmette-Guérin is due principally to trehalose mycolates

1 reference

12 December 2020

Mucosal adjuvant activity of flagellin in aged mice

1 reference

12 December 2020

Upregulation of the 2-5A synthetase/RNase L antiviral pathway associated with chronic fatigue syndrome

1 reference

12 December 2020

TLR ligand suppression or enhancement of Treg cells? A double-edged sword in immunity to tumours

1 reference

12 December 2020

A phase I trial in HIV negative healthy volunteers evaluating the effect of potent adjuvants on immunogenicity of a recombinant gp120W61D derived from dual tropic R5X4 HIV-1ACH320.

1 reference

12 December 2020

Tuberculosis and AIDS – a devilish liaison

1 reference

12 December 2020

Effect of meningococcal endotoxin on the immune response

1 reference

12 December 2020

Cutting edge: cooperation of IPS-1- and TRIF-dependent pathways in poly IC-enhanced antibody production and cytotoxic T cell responses

1 reference

12 December 2020

Cutting edge: alum adjuvant stimulates inflammatory dendritic cells through activation of the NALP3 inflammasome

1 reference

12 December 2020

Safety and immunogenicty of RTS,S/AS02A candidate malaria vaccine in Gambian children

1 reference

12 December 2020

Uptake of particulate vaccine adjuvants by dendritic cells activates the NALP3 inflammasome

1 reference

12 December 2020

Inflammatory caspases and inflammasomes: master switches of inflammation

1 reference

12 December 2020

Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity

1 reference

12 December 2020

Nod2-dependent Th2 polarization of antigen-specific immunity.

1 reference

12 December 2020

Induction of adaptive immunity by flagellin does not require robust activation of innate immunity

1 reference

12 December 2020

The adjuvanticity of interleukin 1 in vivo

1 reference

12 December 2020

Dependence on O2- generation by xanthine oxidase of pathogenesis of influenza virus infection in mice

1 reference

12 December 2020

Critical role for Cryopyrin/Nalp3 in activation of caspase-1 in response to viral infection and double-stranded RNA

1 reference

12 December 2020

Combination of the cationic surfactant dimethyl dioctadecyl ammonium bromide and synthetic mycobacterial cord factor as an efficient adjuvant for tuberculosis subunit vaccines

1 reference

12 December 2020

Boosting our best shot.

1 reference

12 December 2020

Molecular identification of a danger signal that alerts the immune system to dying cells

1 reference

12 December 2020

Isolation and Properties of a Macromolecular, Water-Soluble, Immuno-Adjuvant Fraction from the Cell Wall of Mycobacterium smegmatis

1 reference

12 December 2020

Syk- and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17

1 reference

12 December 2020

Single dose of a vaccine based on DNA encoding mycobacterial hsp65 protein plus TDM-loaded PLGA microspheres protects mice against a virulent strain of Mycobacterium tuberculosis

1 reference

12 December 2020

Pilot evaluation of influenza virus vaccine (IVV) combined with adjuvant

1 reference

12 December 2020

Monophosphoryl lipid A (MPL) formulations for the next generation of vaccines

1 reference

12 December 2020

The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis

1 reference

12 December 2020

Approaching the asymptote? Evolution and revolution in immunology

1 reference

12 December 2020

Cross-protection against H5N1 influenza virus infection is afforded by intranasal inoculation with seasonal trivalent inactivated influenza vaccine.

1 reference

12 December 2020

Synergistic stimulation of human monocytes and dendritic cells by Toll-like receptor 4 and NOD1- and NOD2-activating agonists

1 reference

12 December 2020

IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge

1 reference

12 December 2020

CpG oligonucleotides improve the protective immune response induced by the anthrax vaccination of rhesus macaques

1 reference

12 December 2020

Bacterial flagellin is an effective adjuvant for CD4+ T cells in vivo

1 reference

12 December 2020

Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells

1 reference

12 December 2020

Cell type-specific involvement of RIG-I in antiviral response

1 reference

12 December 2020

10.1007/S11908-009-0080-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21308494%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

1 reference